Back to Search
Start Over
Mesyl Phosphoramidate Oligonucleotides as Potential Splice-Switching Agents: Impact of Backbone Structure on Activity and Intracellular Localization.
- Source :
-
Nucleic Acid Therapeutics . Jun2021, Vol. 31 Issue 3, p190-200. 11p. - Publication Year :
- 2021
-
Abstract
- A series of 2′-deoxy and novel 2′-O-methyl and 2′-O-(2-methoxyethyl) (2′-MOE) oligonucleotides with internucleotide methanesulfonyl (mesyl, μ) or 1-butanesulfonyl (busyl, β) phosphoramidate groups has been synthesized for evaluation as potential splice-switching oligonucleotides. Evaluation of their splice-switching activity in spinal muscular atrophy patient-derived fibroblasts revealed no significant difference in splice-switching efficacy between 2′-MOE mesyl oligonucleotide and the corresponding phosphorothioate (nusinersen). Yet, a survival study with model neonatal mice has shown the antisense 2′-MOE mesyl oligonucleotide to be inferior to nusinersen at the highest dose of 40 mg/kg. A reason for their lower activity in vivo as ascertained by cellular uptake study by fluorescent confocal microscopy in HEK293 cell line could possibly be ascribed to compromised endosomal release and/or nuclear uptake of the 2′-OMe or 2′-MOE μ- and β-oligonucleotides compared to their phosphorothioate analog. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 21593337
- Volume :
- 31
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- Nucleic Acid Therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 150744198
- Full Text :
- https://doi.org/10.1089/nat.2020.0860